Epidemiology of head and neck cancers: an update.

  title={Epidemiology of head and neck cancers: an update.},
  author={Anne Aup{\'e}rin},
  journal={Current Opinion in Oncology},
  • A. Aupérin
  • Published 23 March 2020
  • Medicine
  • Current Opinion in Oncology
PURPOSE OF REVIEW This review attempts to give an update of epidemiological knowledge on head and neck cancers (HNC). RECENT FINDINGS Worldwide, from 1990 to 2017, incidence rates for larynx and nasopharyngeal cancers decreased, whereas they increased for oro/hypopharyngeal cancers and lip/oral cavity cancers. They are still markedly higher among men than women. South Asia has the highest HNC incidence rate, followed by Europe, North America, and Australasia.Tobacco and alcohol remain the… 

The changing face of Irish head and neck cancer epidemiology: 20 years of data

HNC survival in Ireland has improved in line with increasing recognition of the value of multidisciplinary assessment, subspecialisation in cancer care, and targeted therapies based on tumour subsites, and survival in the elderly cohort remains poor.

Laryngeal cancers in paediatric and young adult patients: epidemiology, biology and treatment

Paediatric and adult populations with laryngeal cancer present different clinical, pathological and survival outcomes, and the patient age at the time of disease development underlies genetic and etiological differences with different mutation patterns between young and old patients.

Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea

The positive rate of HPV in Korean patients with OPSCC is significantly high (70.1%), similar to that in North America and Europe, and has increased abruptly in the past 12 years.

A clinician’s dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?

Major health authorities and international gynecologic scientific societies should issue or update specific recommendations, also with the aim of preventing inconsistent health care professionals’ behaviors.

Support group preferences for patients with head and neck cancer: cross-sectional survey

Improved survival means a larger cohort of patients are living with the long-term effects of the cancer and its treatment on their quality of life (QOL) and several new treatments are emerging, such as immunotherapy, which are prolonging the lives of many patients with head and neck cancer.

Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment

Several types of delivery strategies, radiation enhancement, inside-out hyperthermia, and theragnostic approaches are addressed, giving an overview of the applications of nanocarrier systems to the diagnosis and treatment of head and neck cancer.

How can we address the challenge of distant metastases in HNSCC prognosis?

Increase the treatment intensity; new therapeutic strategies, including immunotherapy and proton therapy combined with multi-omics data, i.e. artificial intelligence and radiomics, will be helpful to improve high-risk patients' selection and early detection of the minimal residual disease with circulating ctDNA could contribute in the burden reduction of distant metastases.

Protocol for a systematic review of the financial burden experienced by people affected by head and neck cancer

The purpose of this systematic review is to estimate out-of-pocket costs, reduced or lost income and informal care costs associated with HNC, identify categories of financial burden and investigate which costs predominate when considering financial burden in this population.

Epidemiological Study of Head and Neck Cancer in Al-Baharegion, South West of Saudi Arabia

The study revealed that smoking with its consequences is a significant risk factor for head and cancer in Al-Baha city.

Advances in Head and Neck Cancer Pain

The use of syngeneic/immunocompetent animal models, as well as a new mouse model of perineural invasion, provides novel insights into the pathobiology of HNC pain.



Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Recent data are reviewed to provide insight into several topics, including incidence trends and projections for HPV-positive HNC; the worldwide HPV-attributable fraction; sex disparities in cancer risk; the epidemiology of oral HPV infection; the latency period between infection and cancer; the potential impact of prophylactic HPV vaccination; and prospects for secondary prevention.

Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix

Key research challenges include understanding oral HPV transmission and male predominance, clarifying the role of cofactors, and developing new screening and treatment methods for HPV‐associated HNSCC.

Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States

A large population-based epidemiologic assessment of the U.S. population defines the incidence and demographic burden of HPV-positive OPSCC and finds the favorable prognosis associated with HPV appears to be limited to the oropharynx.

Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol

The results support the independent roles of smoking, alcohol and HPV infection in OPC risk and a possible combined effect and efforts should be made to tackle these major risk factors simultaneously.

Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer

The results suggest that while the contribution of HPV16 is substantial for the oropharynx, it remains limited for oral cavity and laryngeal cancers.

Alcohol and head and neck cancer

The association between alcohol drinking and the survival of individuals with HNC remains unclear, and mortality due to competing causes should be considered in future research to evaluate this association.

The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium.

Good oral hygiene, as characterized by few missing teeth, annual dentist visits, and daily tooth brushing, may modestly reduce the risk of head and neck cancer.

Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990–2017

The global incidence of LOCPs has increased among females, those aged 15 to 49 y, and people from low/middle-income countries over the study period, excepting nasopharyngeal cancers, which had a decreasing worldwide trend.

Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium.

Smokeless tobacco use appears to be associated with HNC, especially oral cancers, with snuff being more strongly associated than chewing tobacco.

Consumption of minimally processed foods as protective factors in the genesis of squamous cell carcinoma of the head and neck in Brazil

The consumption of a heathy diet rich in fruits and vegetables was associated with a reduced risk of HNC, and public policies, including government subsidies, are essential to facilitate logistical and financial access to minimally processed foods, thereby strengthening environments that promote healthy behavior.